STAAR Surgical Announces $50M Buyback Plan
Benzinga Newsdesk 1 day ago
BuybacksNews
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced its authorized $50 million share repurchase program, reflecting its confidence in the business and belief that STAAR’s shares are undervalued.